Kidola Jeremiah (MD, MPhil, PhD)
Kidola Jeremiah (MD, MPhil, PhD)
Clinical research scientist, National Institute for Medical Research, Mwanza research centre
Verified email at nimr.or.tz
Title
Cited by
Cited by
Year
Diabetes is a risk factor for pulmonary tuberculosis: a case-control study from Mwanza, Tanzania
D Faurholt-Jepsen, N Range, G PrayGod, K Jeremiah, M Faurholt-Jepsen, ...
PloS one 6 (8), e24215, 2011
1522011
The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis
MG Aabye, P Ravn, G PrayGod, K Jeremiah, A Mugomela, M Jepsen, ...
PloS one 4 (1), e4220, 2009
1042009
Diabetes is a strong predictor of mortality during tuberculosis treatment: a prospective cohort study among tuberculosis patients from M wanza, T anzania
D Faurholt‐Jepsen, N Range, G PrayGod, K Jeremiah, ...
Tropical Medicine & International Health 18 (7), 822-829, 2013
1002013
Potential of interferon-γ-inducible protein 10 in improving tuberculosis diagnosis in HIV-infected patients
MG Aabye, M Ruhwald, G Praygod, K Jeremiah, M Faurholt-Jepsen, ...
European Respiratory Journal 36 (6), 1488-1490, 2010
642010
Daily multi-micronutrient supplementation during tuberculosis treatment increases weight and grip strength among HIV-uninfected but not HIV-infected patients in Mwanza, Tanzania
G PrayGod, N Range, D Faurholt-Jepsen, K Jeremiah, M Faurholt-Jepsen, ...
The Journal of nutrition 141 (4), 685-691, 2011
592011
Pharmacokinetics of isoniazid, pyrazinamide, and ethambutol in newly diagnosed pulmonary TB patients in Tanzania
P Denti, K Jeremiah, E Chigutsa, D Faurholt-Jepsen, G PrayGod, ...
PloS one 10 (10), e0141002, 2015
582015
Nutritional supplementation increases rifampin exposure among tuberculosis patients coinfected with HIV
K Jeremiah, P Denti, E Chigutsa, D Faurholt-Jepsen, G PrayGod, ...
Antimicrobial agents and chemotherapy 58 (6), 3468-3474, 2014
552014
The role of diabetes on the clinical manifestations of pulmonary tuberculosis
D Faurholt‐Jepsen, N Range, G PrayGod, K Jeremiah, ...
Tropical Medicine & International Health 17 (7), 877-883, 2012
492012
Weight, body composition and handgrip strength among pulmonary tuberculosis patients: a matched cross-sectional study in Mwanza, Tanzania
G PrayGod, N Range, D Faurholt-Jepsen, K Jeremiah, M Faurholt-Jepsen, ...
Transactions of the Royal Society of Tropical Medicine and Hygiene 105 (3 …, 2011
492011
Effects on mortality of a nutritional intervention for malnourished HIV-infected adults referred for antiretroviral therapy: a randomised controlled trial
S Filteau, G PrayGod, L Kasonka, S Woodd, AM Rehman, M Chisenga, ...
BMC medicine 13 (1), 1-13, 2015
462015
Diabetes is associated with lower tuberculosis antigen-specific interferon gamma release in Tanzanian tuberculosis patients and non-tuberculosis controls
D Faurholt-Jepsen, MG Aabye, AV Jensen, N Range, G Praygod, ...
Scandinavian journal of infectious diseases 46 (5), 384-391, 2014
442014
The effect of energy–protein supplementation on weight, body composition and handgrip strength among pulmonary tuberculosis HIV-co-infected patients: randomised controlled …
G PrayGod, N Range, D Faurholt-Jepsen, K Jeremiah, M Faurholt-Jepsen, ...
British Journal of Nutrition 107 (2), 263-271, 2012
432012
Vitamin D status among pulmonary TB patients and non-TB controls: a cross-sectional study from Mwanza, Tanzania
H Friis, N Range, J Changalucha, G PrayGod, K Jeremiah, ...
PloS one 8 (12), e81142, 2013
392013
The role of anthropometric and other predictors for diabetes among urban Tanzanians with tuberculosis
D Faurholt-Jepsen, N Range, G PrayGod, K Jeremiah, M Faurholt-Jepsen, ...
The International journal of tuberculosis and lung disease 16 (12), 1680-1685, 2012
392012
The role of diabetes co-morbidity for tuberculosis treatment outcomes: a prospective cohort study from Mwanza, Tanzania
D Faurholt-Jepsen, N Range, G Praygod, J Kidola, M Faurholt-Jepsen, ...
BMC infectious diseases 12 (1), 1-8, 2012
352012
A systematic review on the effect of HIV infection on the pharmacokinetics of first-line tuberculosis drugs
A Daskapan, LR Idrus, MJ Postma, B Wilffert, JGW Kosterink, Y Stienstra, ...
Clinical pharmacokinetics 58 (6), 747-766, 2019
332019
Resistance to cotrimoxazole and other antimicrobials among isolates from HIV/AIDS and non-HIV/AIDS patients at Bugando Medical Centre, Mwanza, Tanzania
KJ Marwa, MF Mushi, E Konje, PE Alele, J Kidola, MM Mirambo
AIDS research and treatment 2015, 2015
332015
Short-course high-dose liposomal amphotericin b for human immunodeficiency virus–associated cryptococcal meningitis: a phase 2 randomized controlled trial
JN Jarvis, TB Leeme, M Molefi, AA Chofle, G Bidwell, K Tsholo, N Tlhako, ...
Clinical Infectious Diseases 68 (3), 393-401, 2019
302019
BCG vaccination status may predict sputum conversion in patients with pulmonary tuberculosis: a new consideration for an old vaccine?
K Jeremiah, G PrayGod, D Faurholt-Jepsen, N Range, AB Andersen, ...
Thorax 65 (12), 1072-1076, 2010
282010
Negative effect of smoking on the performance of the QuantiFERON TB gold in tube test
MG Aabye, TS Hermansen, M Ruhwald, G PrayGod, D Faurholt-Jepsen, ...
BMC infectious diseases 12 (1), 1-6, 2012
262012
The system can't perform the operation now. Try again later.
Articles 1–20